222 related articles for article (PubMed ID: 30464806)
1. Renin-angiotensin inhibitors reprogram tumor immune microenvironment: A comprehensive view of the influences on anti-tumor immunity.
Vallejo-Ardila DL; Fifis T; Burrell LM; Walsh K; Christophi C
Oncotarget; 2018 Oct; 9(84):35500-35511. PubMed ID: 30464806
[TBL] [Abstract][Full Text] [Related]
2. Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems.
Su JB
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):319-28. PubMed ID: 23386283
[TBL] [Abstract][Full Text] [Related]
3. The role of the renin-angiotensin system inhibitors in malignancy: a review.
Yang J; Yang X; Gao L; Zhang J; Yi C; Huang Y
Am J Cancer Res; 2021; 11(3):884-897. PubMed ID: 33791161
[TBL] [Abstract][Full Text] [Related]
4. Clinical applicability of renin-angiotensin system inhibitors in cancer treatment.
Jiang H; Tai Z; Chen Z; Zhu Q; Bao L
Am J Cancer Res; 2021; 11(2):318-336. PubMed ID: 33575074
[TBL] [Abstract][Full Text] [Related]
5. Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.
Pinter M; Jain RK
Sci Transl Med; 2017 Oct; 9(410):. PubMed ID: 28978752
[TBL] [Abstract][Full Text] [Related]
6. Four decades of ocular renin-angiotensin and kallikrein-kinin systems (1977-2017).
Igić R
Exp Eye Res; 2018 Jan; 166():74-83. PubMed ID: 28549900
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk of the renin-angiotensin and kallikrein-kinin systems.
Shen B; El-Dahr SS
Biol Chem; 2006 Feb; 387(2):145-50. PubMed ID: 16497145
[TBL] [Abstract][Full Text] [Related]
8. The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems.
Dielis AW; Smid M; Spronk HM; Hamulyak K; Kroon AA; ten Cate H; de Leeuw PW
Hypertension; 2005 Dec; 46(6):1236-42. PubMed ID: 16286563
[TBL] [Abstract][Full Text] [Related]
9. Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition.
Kocher F; Tymoszuk P; Amann A; Sprung S; Salcher S; Daum S; Haybaeck J; Rinnerthaler G; Huemer F; Kauffmann-Guerrero D; Tufman A; Seeber A; Wolf D; Pircher A
Lung Cancer; 2021 Sep; 159():84-95. PubMed ID: 34315093
[TBL] [Abstract][Full Text] [Related]
10. [THE ROLE OF KALLIKREIN-KININ AND RENIN- ANGIOTENSIN SYSTEM IN THE PATHOGENESIS OF PROSTATE CANCER].
Kogan MI; Chernogubova EA; Chibichjan MB; Macionis AJ; Povilajtite PJ; Matishov DG
Urologiia; 2015; (3):50-4. PubMed ID: 26390560
[TBL] [Abstract][Full Text] [Related]
11. Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men.
Bukowska A; Spiller L; Wolke C; Lendeckel U; Weinert S; Hoffmann J; Bornfleth P; Kutschka I; Gardemann A; Isermann B; Goette A
Exp Biol Med (Maywood); 2017 Aug; 242(14):1412-1423. PubMed ID: 28661206
[TBL] [Abstract][Full Text] [Related]
12. Use of renin angiotensin system inhibitors in patients with chronic kidney disease.
Adam WR; Wright JR
Intern Med J; 2016 May; 46(5):626-30. PubMed ID: 27170242
[TBL] [Abstract][Full Text] [Related]
13. Is the use of renin-angiotensin system inhibitors in patients with aortic valve stenosis safe and of prognostic benefit? A systematic review and meta-analysis.
Andersson C; Abdulla J
Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):21-27. PubMed ID: 27615013
[TBL] [Abstract][Full Text] [Related]
14. Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.
Zhang Y; Wang L; Song Y; Zhao X; Wong MS; Zhang W
Osteoporos Int; 2016 Mar; 27(3):1083-1092. PubMed ID: 26439241
[TBL] [Abstract][Full Text] [Related]
15. The role of kinin receptors in cancer and therapeutic opportunities.
da Costa PL; Sirois P; Tannock IF; Chammas R
Cancer Lett; 2014 Apr; 345(1):27-38. PubMed ID: 24333733
[TBL] [Abstract][Full Text] [Related]
16. Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions.
Catarata MJ; Ribeiro R; Oliveira MJ; Robalo Cordeiro C; Medeiros R
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32503281
[TBL] [Abstract][Full Text] [Related]
17. The Renin-Angiotensin System in the Tumor Microenvironment of Glioblastoma.
O'Rawe M; Kilmister EJ; Mantamadiotis T; Kaye AH; Tan ST; Wickremesekera AC
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439159
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system.
Regoli D; Gobeil F
Can J Physiol Pharmacol; 2017 Oct; 95(10):1117-1124. PubMed ID: 28384411
[TBL] [Abstract][Full Text] [Related]
20. Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.
Ahmadian E; Pennefather PS; Eftekhari A; Heidari R; Eghbal MA
Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1279-1288. PubMed ID: 27352778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
